BioSpace News Archive

Business

CENTENE CORPORATION SCHEDULES 2022 THIRD QUARTER FINANCIAL RESULTS CONFERENCE CALL

Centene Corporation (NYSE: CNC) today issued a reminder that it will release its 2022 third quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, October 25, 2022, and will host a conference call afterwards at approximately 8:30 a.m. (Eastern Time) to review the results.

October 5, 2022
·
2 min read
BioMidwest

Health Karma(R) Partners with VetCV to Expand Access to Care For Veterans

MediXall Group Inc., an innovative healthcare solutions provider, announced that VetCV has selected MediXall’s wholly-owned subsidiary, Health Karma, Inc., to drive greater access to care for US Veterans.

October 5, 2022
·
4 min read
Business

GreenLight Biosciences and Queensland University of Technology partner to tackle destructive fall armyworm using RNA

GreenLight Biosciences and Queensland University of Technology (QUT) partner to create a solution for fall armyworm.

October 5, 2022
·
3 min read
Lytix Biopharma announces that an abstract has been accepted for poster presentation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Lytix Biopharma today announces that an abstract has been accepted for poster presentation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2022.

October 5, 2022
·
1 min read
Deals

Bayer Completes Sale of Its Environmental Science Professional Business to Cinven

Bayer has completed the sale of its Environmental Science Professional business to the international private equity firm Cinven, after the two companies had entered into a corresponding agreement in March.

October 5, 2022
·
4 min read
Business

The Ohio State University and Battelle Partner to Establish new NeuroTech Institute to Help Advance Neurolgical Research and Treatment

The Ohio State University and Battelle have partnered to launch an independent state-of-the art neurotechnology accelerator focused on treatments for patients with neurological disorders.

October 5, 2022
·
3 min read
DiscGenics to Present at 2022 Cell & Gene Meeting on the Mesa

DiscGenics, Inc. today announced that Flagg Flanagan, Chief Executive Officer and Chairman will present virtually at the annual Cell & Gene Meeting on the Mesa to be held October 11-13 in Carlsbad, California and livestreamed globally.

October 5, 2022
·
2 min read
BioCapital

SYNAPS Dx’s DISCERN™ Diagnostic Test Supports Payer Coverage and Prescribing Decisions for Lecanemab, Expected Breakthrough Treatment of Alzheimer’s Disease

SYNAPS Dx announces support for the nations’ payers in their coverage and prescribing determinations for the AD drug, lecanemab when it is approved as expected by the FDA.

October 5, 2022
·
2 min read
Procaps Group to Participate in the BTG Pactual LatAm CEO Conference

Procaps Group today announced it will participate in the BTG Pactual LatAm CEO Conference being held at the InterContinental NY Barclays Hotel October 11-13, 2022.

October 5, 2022
·
1 min read
CIRM awards $1.3 million to Greenstone Bio for innovative cardiovascular stem cell research

Greenstone Biosciences, Inc. (“Greenstone Bio”), a commercial-stage computational biology company, announces that the Company has received a DISC0 grant funding from the California Institute of Regenerative Medicine (CIRM).

October 5, 2022
·
2 min read